bronchusobstruction recurrent infant wheezing
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
2 Years to 11 Years
Inclusion criteria
Inclusion criteria: patient is early wheezer patient is 3 years of age
Exclusion criteria
Exclusion criteria: The use of systemic immune modulating medication at the time of blood withdrawal and/or 6 weeks before blood withdrawal. The presence of an active infection at the time of blood withdrawal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study endpoint: transient or persistent wheezing (= asthma) at age 6 years. Study determinants: number, phenotype and functionality of regulatory T cells in the peripheral blood of early wheezers at age 3 and 5 years. Details on study determinants will be based on the outcome of the pilotstudy (Regulatory T cells in asthma; ABR nummer 19836) preceding the analysis of the samples of this prospective study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary determinants: Questionnaires: WRC (Weekly Record Card) and questionnaire based upon the ISAAC and PIAMA studies. Lung function: RINTat the age of 3,4,5 and 6 years of age; Volume flow curves before and after β2-mimetics at the age of 6 years. eNose measurement at the age of 3 and 6 years. Peripheral blood: cell numbers and Immunoglobin E levels (total and specific IgE for most common food and inhalent allergens). | — |
Countries
Netherlands
Outcome results
None listed